Skip to content
Back to the Guavy Wire
Stocks

TD Cowen Upgrades UnitedHealth to Buy on Strong Growth Outlook

Instruments
UNH
Share

UnitedHealth Group's stock surged 4% on Friday morning following an upgrade from TD Cowen. The brokerage lifted its rating from Hold to Buy, pointing to improving business conditions and stronger earnings potential. TD Cowen also boosted its price target for UnitedHealth from $402 to $455.

Analyst Ryan Langston highlighted several factors driving the optimistic outlook, including mid-to-high-teens earnings per share growth expected through 2028. Key contributors to this growth include enhancements in Medicare Advantage benefits, a rebound at Optum Health, and better performance in commercial and Medicaid operations.

The brokerage also noted Optum Rx's expansion and the introduction of AI-based products at Optum Insight as additional growth drivers. These developments could help UnitedHealth diversify its revenue streams beyond traditional insurance services.

However, regulatory risks remain a concern. Proposed changes to Medicare Advantage and potential congressional actions could impact the company's near-term performance. Investors will be closely monitoring UnitedHealth's ability to execute its operational recovery and meet its long-term earnings goals.

More on Stocks